Completion of sale
LONDON--(BUSINESS WIRE)--July 31, 2003--
Completion of sale of Tate & Lyle Group's monosodium glutamate unit to Ajinomoto
31 July 2003
Tate & Lyle PLC announces that the sale of its monosodium
glutamate (MSG) production unit in France to Ajinomoto Co., Inc. has
now been completed. The signing of a conditional agreement for this
disposal was announced on 21 November 2002.
For more information contact:
Mark Robinson 020 7626 6525
Chris Fox (Press) 020 7626 6525 (office) or 07801 808553 (mobile)
About Tate & Lyle
Tate & Lyle is a world leader in carbohydrate ingredients. Our core
competence is to take basic carbohydrates - corn, wheat or sugar - and
add value to these raw materials through technology. As a result of
continuous innovation we offer an ever-wider product portfolio of
versatile and functional ingredients. These products include Cereal
Sweeteners, Starches, Sugars and Citric Acid. Our products have wide
applications in the food, beverage, pharmaceutical, cosmetic, paper,
packaging and building industries.
With headquarters in London, Tate & Lyle operates more than 40 plants
in 24 countries, almost all in Europe and the Americas. We employ
6,700 people in our subsidiaries with a further 2,800 employed in
joint ventures. Sales in the year to 31 March 2003 totalled £3,167
billion. More details are available online at www.tateandlyle.com
Short Name: Tate & Lyle PLC
Category Code: MSC
Sequence Number: 00007800
Time of Receipt (offset from UTC): 20030731T091544+0100
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.